Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 276

Sort by

Sort Order Select

Journal Articles

Nbeal2 knockout mice are not protected against hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension

Janelle N. Posey, Mariah Jordan, Caitlin V. Lewis, Christina Sul, Evgenia Dobrinskikh, Delaney Swindle, Frederik Denorme, David Irwin, Jorge Di Paola, Kurt Stenmark, Eva S. Nozik, Cassidy Delaney

Blood Adv (2025) 9 (7): 1571–1584.

https://doi.org/10.1182/bloodadvances.2024013880

Published: 2025

Includes: Supplemental data

Journal Articles

The role of genetic sequencing in the diagnostic workup for chronic immune thrombocytopenia

Nehal Joshi, Hana Lango-Allen, Kate Downes, Ilenia Simeoni, Camelia Vladescu, Deena Paul, Alice Hart, Christine Ademokun, Nichola Cooper

Blood Adv (2025) 9 (7): 1497–1507.

https://doi.org/10.1182/bloodadvances.2024014639

Published: 2025

Includes: Supplemental data

Journal Articles

An αIIbβ3 Ligand-Mimetic Murine Monoclonal Antibody That Produces Platelet Activation by Engaging the FcγIIa Receptor

Jialing Wang, Lorena Buitrago, Lu Wang, Jihong Li, Thomas Walz, Barry S. Coller

Blood Adv bloodadvances.2024015368.

https://doi.org/10.1182/bloodadvances.2024015368

Published: 2025

Includes: Supplemental data

Journal Articles

Pediatric refractory ITP, a definition to be defined

Emilia Parodi, Giovanna Russo

Blood Adv (2025) 9 (5): 1242–1243.

https://doi.org/10.1182/bloodadvances.2024015195

Published: 2025

Journal Articles

Working toward international consensus defining pediatric “refractory ITP”

Candelaria O’Farrell, Amanda Bell Grimes, Taizo A. Nakano, Robert J. Klaassen, Michele P. Lambert, Cindy Neunert, Jennifer A. Rothman, Kristin A. Shimano, Rachael F. Grace

Blood Adv (2025) 9 (5): 1244–1245.

https://doi.org/10.1182/bloodadvances.2024015219

Published: 2025

Journal Articles

Ubiquitous clot contraction blockers hit ubiquitin and more

John W. Weisel, Rustem I. Litvinov

Blood Adv (2025) 9 (5): 1092–1094.

https://doi.org/10.1182/bloodadvances.2024014973

Published: 2025

Journal Articles

α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment

Blood Adv (2025) 9 (5): 1185–1201.

https://doi.org/10.1182/bloodadvances.2024014805

Published: 2025

Includes: Supplemental data

Journal Articles

Platelet potential to switch to procoagulant phenotype compensates bleeding tendency in patients with hemophilia A

Karina Althaus, Sophie Kieninger, Anna Bäuerle, Stefanie Hammer, Nina Wolska, Günalp Uzun, Karoline Weich, Lorenzo Alberio, Alessandro Aliotta, Christoph Faul, Margarete Moyses, Ursula Holzer, Vanya Icheva, David Gorodezki, Sebastian Hörber, Susan Halimeh, Jan Zlamal, Tamam Bakchoul

Blood Adv (2025) 9 (5): 1181–1184.

https://doi.org/10.1182/bloodadvances.2024014785

Published: 2025

Includes: Supplemental data

Journal Articles

Unbiased high-throughput screening of drug-repurposing libraries identifies small-molecule inhibitors of clot retraction

Lorena Buitrago, Miriam-Rose Menezes, Chloe Larson, Jihong Li, Thomas Kartika, Priyam Banerjee, Fraser Glickman, Barry Coller

Blood Adv (2025) 9 (5): 1049–1068.

https://doi.org/10.1182/bloodadvances.2024013810

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of clinical factors on accuracy of ovarian cancer detection via platelet RNA profiling

Maksym A. Jopek, Michał Sieczczyński, Krzysztof Pastuszak, Sylwia Łapińska-Szumczyk, Jacek Jassem, Anna J. Żaczek, Matthew T. Rondina, Anna Supernat

Blood Adv (2025) 9 (5): 979–989.

https://doi.org/10.1182/bloodadvances.2024014008

Published: 2025

Includes: Supplemental data

Journal Articles

Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models

Sankaranarayanan Kannan, Yizhen Li, Natalia Baran, Xu Yang, Sanaz Ghotbaldini, Qi Zhang Tatarata, Satoshi Yoshimura, Zhenhua Li, YuChih Hsiao, Srividya Balachander, Courtney L. Andersen, Justin Cidado, Jiyang Yu, Nitin Jain, Jun J. Yang, Marina Konopleva

Blood Adv (2025) 9 (3): 473–487.

https://doi.org/10.1182/bloodadvances.2024013423

Published: 2025

Includes: Supplemental data

Journal Articles

Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study

Blood Adv (2025) 9 (3): 488–495.

https://doi.org/10.1182/bloodadvances.2024014984

Published: 2025

Includes: Supplemental data

Journal Articles

Is GPIbα really a master regulator of platelet activation?

Brianna E. Watson, Isabelle I. Salles-Crawley

Blood Adv (2025) 9 (2): 427–428.

https://doi.org/10.1182/bloodadvances.2024014324

Published: 2025

Journal Articles

Efficacy and safety of dapsone in adult primary immune thrombocytopenia

Blood Adv bloodadvances.2024014939.

https://doi.org/10.1182/bloodadvances.2024014939

Published: 2025

Includes: Supplemental data

Journal Articles

Elritercept, a modified activin receptor IIA ligand trap, increased erythropoiesis and thrombopoiesis in a phase 1 trial

Jennifer Lachey, Christopher Rovaldi, Suresh Bobba, Jared Tur, Harveen Natarajan, Ben Snyder, Jasbir Seehra

Blood Adv (2025) 9 (1): 193–201.

https://doi.org/10.1182/bloodadvances.2024014172

Published: 2025

Includes: Supplemental data

Journal Articles

Serglycin controls megakaryocyte retention of platelet factor 4 and influences megakaryocyte fate in bone marrow

Joshua Lykins, Isabelle C. Becker, Virginia Camacho, Hammodah R. Alfar, JoonWoo Park, Joseph Italiano, Sidney W. Whiteheart

Blood Adv (2024) 9 (1): 15–28.

https://doi.org/10.1182/bloodadvances.2024012995

Published: 2024

Includes: Supplemental data

Journal Articles

Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies

Margaux Soulard, Lionel Galicier, Nizar Mahlaoui, Claire Fieschi, Samuel Deshayes, Delphine Gobert, Clément Gourguechon, Hélène Henique, Sebastien Humbert, Carole Lacout, Ronan Le Calloch, Marc Michel, Marie-lea Piel-julian, Jean François Viallard, Alain Lescoat, Bertrand Godeau, Antoinette Perlat

Blood Adv (2024) 8 (24): 6171–6182.

https://doi.org/10.1182/bloodadvances.2024014370

Published: 2024

Journal Articles

Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia

Alexandra Schifferli, Gautier Le Gavrian, Nathalie Aladjidi, Guillaume Moulis, Bertrand Godeau, Thierry Leblanc, Sébastien Héritier, Helder Fernandes, Thomas Kühne

Blood Adv (2024) 8 (24): 6183–6194.

https://doi.org/10.1182/bloodadvances.2024014381

Published: 2024

Includes: Supplemental data

Journal Articles

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Halina H. L. Leung, Zohra Ahmadi, Brendan Lee, John Casey, Sumita Ratnasingam, Steven E. McKenzie, Jose Perdomo, Beng H. Chong

Blood Adv (2024) 8 (22): 5744–5752.

https://doi.org/10.1182/bloodadvances.2024013883

Published: 2024

Includes: Supplemental data

Journal Articles

Btk inhibition: the importance of being selective

Robert Flaumenhaft

Blood Adv (2024) 8 (21): 5579–5580.

https://doi.org/10.1182/bloodadvances.2024014009

Published: 2024

NARROW

Nbeal2 knockout mice are not protected against hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension

The role of genetic sequencing in the diagnostic workup for chronic immune thrombocytopenia

An αIIbβ3 Ligand-Mimetic Murine Monoclonal Antibody That Produces Platelet Activation by Engaging the FcγIIa Receptor

Pediatric refractory ITP, a definition to be defined

Working toward international consensus defining pediatric “refractory ITP”

Ubiquitous clot contraction blockers hit ubiquitin and more

α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment

Platelet potential to switch to procoagulant phenotype compensates bleeding tendency in patients with hemophilia A

Unbiased high-throughput screening of drug-repurposing libraries identifies small-molecule inhibitors of clot retraction

Impact of clinical factors on accuracy of ovarian cancer detection via platelet RNA profiling

Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models

Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study

Is GPIbα really a master regulator of platelet activation?

Efficacy and safety of dapsone in adult primary immune thrombocytopenia

Elritercept, a modified activin receptor IIA ligand trap, increased erythropoiesis and thrombopoiesis in a phase 1 trial

Serglycin controls megakaryocyte retention of platelet factor 4 and influences megakaryocyte fate in bone marrow

Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies

Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Btk inhibition: the importance of being selective

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only